BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20850259)

  • 21. Retaining counseling staff at substance abuse treatment centers: effects of management practices.
    Knudsen HK; Johnson JA; Roman PM
    J Subst Abuse Treat; 2003 Mar; 24(2):129-35. PubMed ID: 12745030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics.
    Knudsen HK; Ducharme LJ; Roman PM
    J Addict Dis; 2007; 26(1):41-50. PubMed ID: 17439867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communities.
    Guerrero EG; He A; Kim A; Aarons GA
    Adm Policy Ment Health; 2014 Nov; 41(6):737-49. PubMed ID: 24046236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Organizational Readiness for Change scale in adolescent programs: Criterion validity.
    Saldana L; Chapman JE; Henggeler SW; Rowland MD
    J Subst Abuse Treat; 2007 Sep; 33(2):159-69. PubMed ID: 17434703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of ownership on access in outpatient substance abuse treatment.
    Nahra TA; Alexander J; Pollack H
    J Subst Abuse Treat; 2009 Jun; 36(4):355-65. PubMed ID: 19339142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.
    Paino M; Aletraris L; Roman PM
    Subst Abus; 2015; 36(4):462-9. PubMed ID: 25257691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations.
    Knudsen HK; Oser CB; Abraham AJ; Roman PM
    J Subst Abuse Treat; 2012 Sep; 43(2):152-60. PubMed ID: 22301083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the organization, management, and outcomes of substance abuse treatment programs.
    Heinrich CJ; Lynn LE
    Am J Drug Alcohol Abuse; 2002 Nov; 28(4):601-22. PubMed ID: 12492259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.
    Terry-McElrath YM; Chriqui JF; McBride DC
    Health Serv Res; 2011 Apr; 46(2):632-53. PubMed ID: 21105870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addiction providers. Surviving isn't enough.
    Enos G
    Behav Healthc Tomorrow; 2002 Apr; 11(2):SR36-8. PubMed ID: 11963691
    [No Abstract]   [Full Text] [Related]  

  • 31. Detrimental Effects of "Stretch" Goals in Specialty Substance Use Disorder Treatment Organizations.
    Lemoine GJ; Blum TC; Roman PM
    J Subst Abuse Treat; 2016 May; 64():13-23. PubMed ID: 26976811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.
    Roman PM; Abraham AJ; Rothrauff TC; Knudsen HK
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S44-52. PubMed ID: 20307795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminating contingency management to increase attendance in two community substance abuse treatment centers: lessons learned.
    Walker R; Rosvall T; Field CA; Allen S; McDonald D; Salim Z; Ridley N; Adinoff B
    J Subst Abuse Treat; 2010 Oct; 39(3):202-9. PubMed ID: 20598838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure.
    Oser CB; Tindall MS; Leukefeld CG
    J Subst Abuse Treat; 2007 Apr; 32(3):301-10. PubMed ID: 17383554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion of contingency management and attitudes regarding its effectiveness and acceptability.
    Bride BE; Abraham AJ; Roman PM
    Subst Abus; 2010 Jul; 31(3):127-35. PubMed ID: 20687001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation.
    Abraham AJ; Knudsen HK; Rothrauff TC; Roman PM
    J Subst Abuse Treat; 2010 Apr; 38(3):275-83. PubMed ID: 20117908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams.
    Blum TC; Davis CD; Roman PM
    J Health Hum Serv Adm; 2014; 37(1):37-75. PubMed ID: 25004707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical supervision: a working model for substance abuse acute care settings.
    Rizzo MD
    Health Care Manag (Frederick); 2003; 22(2):136-43. PubMed ID: 12785551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.
    Knudsen HK; Ducharme LJ; Roman PM
    Drug Alcohol Depend; 2007 Mar; 87(2-3):164-74. PubMed ID: 16971059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organizational readiness for change in community-based addiction treatment programs and adherence in implementing evidence-based practices: a national study.
    Lundgren L; Amodeo M; Chassler D; Krull I; Sullivan L
    J Subst Abuse Treat; 2013; 45(5):457-65. PubMed ID: 23928378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.